BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 6.02.2026

FDA Announces Availability of Draft Guidance for Patient Preference Studies

The FDA has released a draft guidance for industry on general considerations for patient preference studies, prepared by the International Council for Harmonisation, aimed at informing drug development and regulatory submissions.

Source: Federal Register — Food and Drug AdministrationOpen original release →